Contribution to pathogenesis of accessory proteins of deadly human coronaviruses

Front Cell Infect Microbiol. 2023 May 1:13:1166839. doi: 10.3389/fcimb.2023.1166839. eCollection 2023.

Abstract

Coronaviruses (CoVs) are enveloped and positive-stranded RNA viruses with a large genome (∼ 30kb). CoVs include essential genes, such as the replicase and four genes coding for structural proteins (S, M, N and E), and genes encoding accessory proteins, which are variable in number, sequence and function among different CoVs. Accessory proteins are non-essential for virus replication, but are frequently involved in virus-host interactions associated with virulence. The scientific literature on CoV accessory proteins includes information analyzing the effect of deleting or mutating accessory genes in the context of viral infection, which requires the engineering of CoV genomes using reverse genetics systems. However, a considerable number of publications analyze gene function by overexpressing the protein in the absence of other viral proteins. This ectopic expression provides relevant information, although does not acknowledge the complex interplay of proteins during virus infection. A critical review of the literature may be helpful to interpret apparent discrepancies in the conclusions obtained by different experimental approaches. This review summarizes the current knowledge on human CoV accessory proteins, with an emphasis on their contribution to virus-host interactions and pathogenesis. This knowledge may help the search for antiviral drugs and vaccine development, still needed for some highly pathogenic human CoVs.

Keywords: MERS-CoV; SARS-CoV; SARS-CoV-2; accessory proteins; coronavirus; innate immune response; pathogenesis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents
  • Coronavirus Infections*
  • Coronavirus* / genetics
  • Humans
  • Viral Proteins / genetics
  • Virulence

Substances

  • Viral Proteins
  • Antiviral Agents

Grants and funding

This work was supported by grants from the Government of Spain (PID2019-107001RB-I00 AEI/FEDER, UE; SEV 2017-0712 and PIE_INTRAMURAL_Ref.-202020E079), the CSIC (PIE_INTRAMURAL-202020E043), the European Commission (ISOLDA_848166 H2020-SC1-2019; MANCO_101003651 H2020-SC1-PHE-CORONAVIRUS-2020), and the U.S. National Institutes of Health (NIH_2P01AI060699). JH-T received a fellowship from PID2019-107001RB-I00 AEI/FEDER, UE. RR-P received a fellowship from Arnhold de la Camara Foundation. MB-P received a contract from ISOLDA Project and a Jose Castillejo fellowship for PhDs mobility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.